PARP1 and neoplasm: PARP inhibitors can generate tumor-derived double-stranded DNA in the cytoplasm, which is sensed by the cytosolic DNA sensor cyclic GMP-AMP synthase, thus activating the stimulator of interferon (IFN) genes (STING) signaling pathway [117].